PER 0.00% 13.5¢ percheron therapeutics limited

could the sp do it again?, page-26

  1. 2,978 Posts.
    lightbulb Created with Sketch. 124
    I don't agree samfiodiving, and I say this purely on

    the grounds that ANP don't want to do a CR they are

    pinning there hopes on a deal. Tapping the market

    imo would not bod well for ANP ST, however LT to self

    fund the next phases could be well rewarded. Having a

    pharma on board will form a solid base for ANP to start

    and build on. I am eager to buy more however at this stage

    imo ANP sits in limbo land as we wait for what direction

    management are going to take, and I hope it is not CR. JMO
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.